cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Assertio Holdings Inc
53 own
27 watching
Current Price
$1.1
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
118.22M
52-Week High
52-Week High
2.60000
52-Week Low
52-Week Low
0.73000
Average Volume
Average Volume
0.43M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization118.22M
icon52-Week High2.60000
icon52-Week Low0.73000
iconAverage Volume0.43M
iconDividend Yield--
iconP/E Ratio--
What does the Assertio Holdings Inc do?
Depomed, Inc., a specialty pharmaceutical company, engages in the development, sale, and licensing of products for pain and other central nervous system conditions in the United States. It offers Gralise (gabapentin), an once-daily product for the management of postherpetic neuralgia; CAMBIA (diclofenac potassium for oral solution), a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks in adults; Zipsor (diclofenac potassium) liquid filled capsule, a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain in adults; and Lazanda (fentanyl) nasal spray, an intranasal fentanyl drug used to manage breakthrough pain in adults. The company also provides NUCYNTA ER (tapentadol extended release tablets), a product for the management of pain severe enough to long term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults; and NUCYNTA (tapentadol), a product for the management of moderate to severe acute pain in adults. In addition, it is involved in the clinical development of Cebranopadol for the treatment of chronic nociceptive and neuropathic pain. The company sells its products to wholesalers and retail pharmacies. It also has a portfolio of license agreements based on its proprietary Acuform gastroretentive drug delivery technology with Mallinckrodt Inc.; Ironwood Pharmaceuticals, Inc.; and Janssen Pharmaceuticals, Inc. The company was founded in 1995 and is headquartered in Newark, California.
Read More
How much money does Assertio Holdings Inc make?
News & Events about Assertio Holdings Inc.
Globe Newswire
1 year ago
NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Amedisys, Inc. (NASDAQ: AMED)s sale to Option ...
Globe Newswire
1 year ago
LAKE FOREST, Ill., May 05, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (Assertio or the Company) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that it will release first quarter 2023 financial results on Tuesday, May 9, 2023, ...
Globe Newswire
1 year ago
NEW YORK, May 02, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Iveric bio, Inc. (NASDAQ: ISEE)s sale to ...
Globe Newswire
1 year ago
NEW YORK, April 29, 2023 (GLOBE NEWSWIRE) -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of HOTH with Algorithm Sciences, Inc., whereby HOTH shareholders are expected to own approximately ...
PR Newswire
1 year ago
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHBI, CBIO, TA, ASRT SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHBI, CBIO, TA, ASRT PR Newswire NEW YORK, April 28, 2023 NEW YORK, April 28, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating...
Frequently Asked Questions
Frequently Asked Questions
What is Assertio Holdings Inc share price today?
plus_minus_icon
Can Indians buy Assertio Holdings Inc shares?
plus_minus_icon
How can I buy Assertio Holdings Inc shares from India?
plus_minus_icon
Can Fractional shares of Assertio Holdings Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Assertio Holdings Inc stocks?
plus_minus_icon
What is today’s traded volume of Assertio Holdings Inc?
plus_minus_icon
What is today’s market capitalisation of Assertio Holdings Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Assertio Holdings Inc?
plus_minus_icon
What percentage is Assertio Holdings Inc down from its 52-Week High?
plus_minus_icon
What percentage is Assertio Holdings Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.1
$0
(0%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
RELMADA THERAPEUTICS INC
RELMADA THERAPEUTICS INC
$3.38
$-0.11 (-3.15 %)
PRAXIS PRECISION MEDICINES I
PRAXIS PRECISION MEDICINES I
$63.10
$-1.67 (-2.58 %)
CUE BIOPHARMA INC
CUE BIOPHARMA INC
$1.21
$-0.02 (-1.63 %)
Greenwich LifeSciences Inc
Greenwich LifeSciences Inc
$12.86
$-0.69 (-5.09 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
RELMADA THERAPEUTICS INC
RELMADA THERAPEUTICS INC
$3.38
$-0.11 (-3.15 %)
PRAXIS PRECISION MEDICINES I
PRAXIS PRECISION MEDICINES I
$63.10
$-1.67 (-2.58 %)
CUE BIOPHARMA INC
CUE BIOPHARMA INC
$1.21
$-0.02 (-1.63 %)
Greenwich LifeSciences Inc
Greenwich LifeSciences Inc
$12.86
$-0.69 (-5.09 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00